H. Hansen

Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.

Andrea Ardizzoni, H. Hansen, P Dombernowsky et al. · Journal of Clinical Oncology · 1997 · 479 citations

Transperineal ¹²⁵ Iodine Seed Implantation in Prostatic Cancer Guided by Transrectal Ultrasonography

H. H. Holm, Niels Juul, Jan Fog Pedersen et al. · The Journal of Urology · 1983 · 452 citations

Radioactive 125Iodine, Urology, Radiation Medicine +14

Post-traumatic Avascular Necrosis of the Humeral Head in Displaced Proximal Humeral Fractures

CASEY K. LEE, H. Hansen · The Journal of Trauma: Injury, Infection, and Critical Care · 1981 · 179 citations

Skeletal Trauma, Post-traumatic Avascular Necrosis, Nineteen Patients +9

Phase I and pharmacokinetics study of topotecan, a new topoisomerase I inhibitor

Jaap Verweij, Birthe Lund, Jos H. Beijnen et al. · Annals of Oncology · 1993 · 123 citations · Full text

Pharmaceutical Science, New Topoisomerase, Medicine +7

Ultrasonically guided percutaneous interstitial implantation of iodine 125 seeds in cancer therapy

H. H. Holm, I. Strøyer, H. Hansen et al. · British Journal of Radiology · 1981 · 30 citations

Cancer Therapy, Percutaneous Interstitial Implantation, Medical Ultrasound +14